Biomerica (NASDAQ:BMRA) Stock Price Passes Below 200 Day Moving Average of $3.33

Shares of Biomerica, Inc. (NASDAQ:BMRAGet Rating) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $3.33 and traded as low as $3.04. Biomerica shares last traded at $3.23, with a volume of 14,631 shares.

Biomerica Trading Up 4.5 %

The firm’s 50 day simple moving average is $3.60 and its two-hundred day simple moving average is $3.33. The firm has a market cap of $43.37 million, a price-to-earnings ratio of -8.07 and a beta of -0.53.

Biomerica (NASDAQ:BMRAGet Rating) last issued its earnings results on Monday, August 29th. The company reported ($0.14) EPS for the quarter. The firm had revenue of $5.30 million during the quarter. Biomerica had a negative net margin of 26.29% and a negative return on equity of 57.33%.

Hedge Funds Weigh In On Biomerica

Institutional investors have recently added to or reduced their stakes in the stock. Jane Street Group LLC acquired a new position in Biomerica during the 1st quarter worth approximately $57,000. Russell Investments Group Ltd. bought a new stake in Biomerica during the 3rd quarter worth approximately $124,000. Finally, Granahan Investment Management LLC grew its holdings in Biomerica by 6.1% during the 1st quarter. Granahan Investment Management LLC now owns 1,169,841 shares of the company’s stock worth $5,229,000 after acquiring an additional 67,268 shares during the last quarter. 18.88% of the stock is currently owned by institutional investors and hedge funds.

About Biomerica

(Get Rating)

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

Further Reading

Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.